These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9602416)

  • 21. The effectiveness of the national hepatitis B vaccination program 25 years after its introduction in Iran: a historical cohort study.
    Moghadami M; Dadashpour N; Mokhtari AM; Ebrahimi M; Mirahmadizadeh A
    Braz J Infect Dis; 2019; 23(6):419-426. PubMed ID: 31678055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up].
    Zhang L; Lyu J; Yan B; Liu J; Feng Y; Chen S; Zhou L; Liang X; Cui F; Wang F; Xu A
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):782-7. PubMed ID: 26733135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
    Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
    J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B vaccinations among Koreans: Results from 2005 Korea National Cancer Screening Survey.
    Juon HS; Choi KS; Park EC; Kwak MS; Lee S
    BMC Infect Dis; 2009 Nov; 9():185. PubMed ID: 19930718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
    Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
    Alanko Blomé M; Björkman P; Flamholc L; Jacobsson H; Widell A
    Vaccine; 2017 Jan; 35(1):84-90. PubMed ID: 27894721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
    Mast EE; Weinbaum CM; Fiore AE; Alter MJ; Bell BP; Finelli L; Rodewald LE; Douglas JM; Janssen RS; Ward JW;
    MMWR Recomm Rep; 2006 Dec; 55(RR-16):1-33; quiz CE1-4. PubMed ID: 17159833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
    Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
    World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer prevention by vaccination against hepatitis B.
    Chang MH
    Recent Results Cancer Res; 2009; 181():85-94. PubMed ID: 19213561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The epidemiological characteristics of HBV susceptibility in 1-29 years old young people in China in 2006 and 2014: based on the national sero-survey data analysis].
    Zheng H; Wang FZ; Zhang GM; Miao N; Sun XJ; Cui FQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):581-586. PubMed ID: 28693080
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of Liver Cancer Through the Early Detection of Risk-related Behavior Among Hepatitis B or C Carriers.
    Fan JY; Huang TJ; Jane SW; Chen MY
    Cancer Nurs; 2015; 38(3):169-76. PubMed ID: 24836958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis B vaccine and liver cancer].
    Lebossé F; Zoulim F
    Bull Cancer; 2021 Jan; 108(1):90-101. PubMed ID: 33358507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
    Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
    Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study.
    Sun Z; Zhu Y; Stjernsward J; Hilleman M; Collins R; Zhen Y; Hsia CC; Lu J; Huang F; Ni Z
    Cancer Detect Prev; 1991; 15(4):313-8. PubMed ID: 1665400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients.
    Stärkel P; Stoffel M; Lerut J; Horsmans Y
    Liver Transpl; 2005 Oct; 11(10):1228-34. PubMed ID: 16184571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
    Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.